What types of pain are addressed by palliative care in patients with chronic, severe, or life-limiting illnesses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Types of Pain Addressed by Palliative Care

Palliative care addresses multiple distinct pain types including nociceptive pain (both somatic and visceral), neuropathic pain, cardiac ischemic pain, musculoskeletal pain, and procedure-related pain, with treatment selection based on the underlying pathophysiological mechanism rather than a one-size-fits-all approach. 1

Primary Pain Categories in Palliative Care

Nociceptive Pain

  • Cancer-related pain is the most extensively studied, affecting 60-90% of cancer patients and requiring assessment of both intensity and mechanism 2, 3
  • Bone pain from metastases is specifically addressed with bisphosphonates in breast cancer and myeloma patients, alongside NSAIDs and opioids 1, 4
  • Visceral pain from organ involvement, tense ascites, or dyspepsia requires mechanism-based treatment 1
  • Somatic pain from musculoskeletal sources, oedematous legs, or peripheral vascular disease 1

Neuropathic Pain

  • Requires distinct pharmacological approaches using antidepressants (tricyclic antidepressants) and anticonvulsants as first-line agents 2, 3
  • Opioids serve as second-line therapy for neuropathic pain, though they remain effective across all pain types 2, 3

Cardiac Ischemic Pain

  • Chronic refractory angina despite optimal cardiologic treatment may require spinal cord stimulation 1
  • Acute coronary syndrome pain is managed with intravenous strong opioids like morphine 1
  • This pain type is particularly relevant in heart failure patients, where pain prevalence reaches 89% in NYHA Class IV 1

Procedure-Related Pain

  • Turning is the most painful procedure for ICU adults 1
  • Endotracheal suctioning causes moderate to severe pain in over 30% of cancer patients and post-cardiac/abdominal surgery patients 1
  • Invasive procedures including chest tube removal, central line insertion, femoral sheath removal, arterial catheter insertion, and wound care all generate significant pain requiring proactive management 1

Pain Assessment Framework

For Communicative Patients

  • Use a 0-10 Numeric Rating Scale (NRS) as the primary tool, validated as the most feasible in ICU settings 1
  • Patients can respond verbally or by pointing to numbers 1
  • Assessment must occur regularly and periodically for all patients with serious illness 1, 5

For Non-Communicative Patients

  • Rely on behavioral pain indicators and physical signs, though this population remains less well understood 1

Pain Management by Mechanism

Nociceptive Pain Management

  • Non-opioid analgesics are ideal first-line agents for nociceptive pain 2
  • Paracetamol is safe in heart failure patients 1
  • NSAIDs must be avoided in heart failure due to fluid retention risk and increased renal strain, particularly with concurrent loop diuretics and ACE inhibitors 1
  • Topical NSAIDs may be tried but lack safety data in heart failure 1

Neuropathic Pain Management

  • Antidepressants and anticonvulsants reduce neuropathic pain intensity as first-line therapy 2
  • Opioids remain effective but are restricted to second-line choice 2

Opioid Selection Considerations

  • Morphine is essential for quality end-of-life care for both pain and dyspnea 4, 5
  • Avoid morphine in significant renal impairment (GFR <30 mL/min) due to active metabolites with renal excretion; switch to alternative opioids 1
  • Tilidine and Tramadol are prodrugs requiring hepatic activation and are vulnerable to drug-drug interactions that block conversion 2
  • Rapid-release opioids should be used for breakthrough cancer pain 2
  • Transdermal opioid applications are recommended for swallowing disorders but not for initiating pain control 2

Special Population Considerations

Heart Failure Patients

  • Pain prevalence increases with age and functional class, reaching 89% in NYHA Class IV 1
  • At least moderate pain affects 61% of hospitalized heart failure patients 1
  • 40% experience pain at multiple sites 1
  • Inadequately treated chronic pain correlates with fatigue, depression, and more frequent hospital admissions 1
  • Palliative care service involvement improves pain burden in both inpatient and outpatient settings 1

Critical Care Patients

  • 70-77% recall pain during ICU treatment, with 63-64% rating it as moderate or severe 1
  • Pain, dyspnea, and thirst are the most prevalent and distressing physical symptoms 1

Critical Pitfalls to Avoid

  • Undertreatment of pain occurs more frequently in heart failure patients compared to cancer patients 1
  • Women and minority groups have cancer pain undertreated more frequently 6
  • Chronic non-cancer pain requires non-pharmacologic and non-opioid pharmacologic therapy as preferred approaches, with careful risk-benefit analysis for long-term opioid use 1
  • Opioid-induced delayed gastric emptying can delay absorption of oral antiplatelet agents; use crushed tablets, prokinetic drugs, or parenteral loading to overcome this effect 1
  • Inadequate pain assessment remains a fundamental barrier, as more than 80% of cancer pain patients can achieve adequate relief through simple pharmacological methods 6

Refractory Pain Management

When pain cannot be adequately controlled despite aggressive efforts, the symptom is designated as refractory if further interventions are incapable of providing relief, associated with excessive morbidity, or unlikely to provide relief within a tolerable timeframe 1

Palliative sedation is indicated as a last resort for refractory symptoms including pain, using supervised administration of sedative medications to induce decreased or absent awareness 1, 4, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Basic knowledge of drug pain therapy in the palliative situation].

Deutsche medizinische Wochenschrift (1946), 2025

Guideline

Management of End-of-Life Signs and Symptoms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

End-of-Life Care Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute and chronic pain management in palliative care.

Best practice & research. Clinical obstetrics & gynaecology, 2001

Related Questions

What should be included in a treatment plan for a patient requiring palliative care?
What is the role of Dilaudid (hydromorphone) in palliative pain management?
What is the best approach for managing end of life care?
What is the difference between hospice and palliative care for patients with serious or terminal illnesses?
What is the difference between hospice care and palliative care for patients with serious or terminal illnesses?
What is the differential diagnosis for an adult patient with an ovoid, iso/hypoechoic (isoechogenic/hypoechogenic), solid, and striated mass in the right lower back, with difficult-to-define margins, that reduces in size with probe pressure and has grown approximately 2 cm since the previous ultrasound (US) examination, initially thought to be a lipoma?
What are the treatment options for a patient with Temporomandibular Joint (TMJ) disorders, considering their medical history and symptoms?
What is the best treatment approach for a patient with Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Post-Traumatic Stress Disorder (PTSD), insomnia, and chronic pain, currently taking Norco (Hydrocodone/Acetaminophen) 5/325mg QID (four times a day), Gabapentin 600mg TID (three times a day), and Trazodone 100mg BID (twice a day), with a history of ineffective treatment with Duloxetine (60mg daily) and Buspar (Buspirone) 10mg TID, and previous trials of most Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)?
What is the best management approach for a patient with iron deficiency anemia and ongoing bleeding, considering treatment with iron sucrose (iron sucrose)?
What should be done for an elderly woman with progressive pulmonary fibrosis and a valid Do Not Intubate (DNI) order who develops respiratory distress, while her son requests intubation despite the DNI order?
What is the best treatment approach for a patient with a traumatic brain injury (TBI) presenting with autonomic dysfunction symptoms and hypertension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.